SRINIVASA PUNYALA: Open Payments
NPI 1891134599 · HOPEWELL, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,796 in 143 payments from 16 companies in 2025. Trend: 2023 $2,334 · 2024 $3,410 · 2025 $2,796
Food & beverage: $2,796
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 18 | $380 |
| Alkermes, Inc. | 14 | $370 |
| ABBVIE INC. | 20 | $287 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $284 |
| Lundbeck LLC | 12 | $229 |
| Teva Pharmaceuticals USA, Inc. | 13 | $201 |
| Janssen Pharmaceuticals, Inc | 6 | $186 |
| E.R. Squibb & Sons, L.L.C. | 13 | $185 |
| Vanda Pharmaceuticals Inc. | 7 | $150 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
Products named: INGREZZA, ARISTADA, VRAYLAR, CAPLYTA, ABILIFY ASIMTUFII, SPRAVATO, COBENFY, FANAPT.
Industry payments across VA — which companies pay providers there.
